Johnson & Johnson Agrees To Pay More Than $2.2 Billion To Resolve Investigations
The U. S. Department of Justice announced on November 4, 2013 that Johnson & Johnson (“J & J”) has agreed to pay in excess of $2.2 billion to resolve civil and criminal investigations relating to J & J’s prescription drugs Risperdal, Invega, and Natrecor. The allegat[...]